REFERENCES
- Cannell JJ, Vieth R, Umhau JC, et al. Epidemic influenza and vitamin D. Epidemiol Infect. 2006;134(6):1129–1140.
- Kriesel JD, Spruance J. Calcitriol (1,25-dihydroxy-vita-min D3) coadministered with influenza vaccine does not enhance humoral immunity in human volunteers. Vaccine. 1999;17(15-16):1883–1888.
- Chadha MK, Fakih M, Muindi J, et al. Effect of 25-hydroxyvitamin D status on serological response to influenza vaccine in prostate cancer patients. Prostate. 2010;71(4):368–372.
- Klein MB, Lu Y, DelBalso L, Cote S, Boivin G. Influenzavi-rus infection is a primary cause of febrile respiratory illness in HIV-infected adults, despite vaccination. Clin Infect Dis. 2007;45(2):234–240.
- Radwan HM, Cheeseman SH, Lai KK, Ellison IR. Influ-enza in human immunodeficiency virus-infected patients during the 1997-1998 influenza season. Clin Infect Dis. 2000;31(2):604–606.
- Evison J, Farese S, Seitz M, Uehlinger DE, Furrer H, Muhle-mann K. Randomized, double-blind comparative trial of subunit and virosomal influenza vaccines for immunocom-promised patients. Clin Infect Dis. 2009;48(10):1402–1412.
- Kroon FP, van Dissel JT, de Jong JC, Zwinderman K, van Furth R. Antibody response after influenza vaccination in HIV-infected individuals: a consecutive 3-year study. Vac-cine. 2000;18(26):3040–3049.
- Fairfield KM, Eisenberg DM, Davis RB, Libman H, Phillips RS. Patterns of use, expenditures, and perceived efficacy of complementary and alternative therapies in HIV-infected patients. Arch Intern Med. 1998;158(20):2257–2264.
- Josephs JS, Fleishman JA, Gaist P, Gebo KA. Use of com-plementary and alternative medicines among a multistate, multisite cohort of people living with HIV/AIDS. HIV Med. 2007;8(5):300–305.
- Cooper C, Thorne A, Klein M, et al. Immunogenicity is not improved by increased antigen dose or booster dosing of seasonal influenza vaccine in a randomized trial of HIV infected adults. PLoS One. 2011;6(3):e17758.